Novo Nordisk stock after-hours at EUR 33.51: minus 0.18 percent versus Lang & Schwarz prior close
Published on 10/01/2026 at 21:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novo Nordisk was at EUR 33.51 in after-hours trading at 9:01 p.m. CEST on October 1, 2026, down 0.18 percent versus the prior close of EUR 33.57 at Lang & Schwarz.
After-hours trading
The latest Lang & Schwarz quote was EUR 33.51, compared with a bid of EUR 33.47 and an ask of EUR 33.56. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Novo Nordisk stock.
Wegovy pill data presented at EASD
In a September 30, 2026 release, Novo Nordisk reported real-world OCTANE data on adults who switched from injectable semaglutide or tirzepatide to once-daily oral semaglutide for weight management. Participants who remained on treatment for three months lost an average of 4.1 percent of body weight, or 4.0 kilograms, according to the company.
The release said 40.7 percent of participants achieved at least 5 percent weight loss after three months. The OCTANE analysis was presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan on September 30, 2026.
